ESR Projects

The 10 proEVLifeCycle ESR projects

ESR1

Manipulating EV uptake and production for therapeutic intervention of prostate cancer progression

Erasmus MC, Rotterdam, The Netherlands
Prof. dr. Guido Jenster (proEVLifeCycle coordinator) and Dr. Martin van Royen

ESR2

Characterizing EV sub-population manufacture/secretion by prostate cancer cells, to identify vesicle subpopulation(s) that are functionally relevant for disease propagation and relevant as biomarkers

Cardiff University, Cardiff, United Kingdom
Prof. dr. Aled Clayton and Dr. Jason Webber

ESR3

EV glycosylations as therapeutic and diagnostic targets of prostate cancer

University of Turku, Finland
Dr. Urpo Lamminmäki and Dr. Janne Leivo

ESR4

Exosome transport and uptake across biological barriers

AIT Austrian Institute of Technology, Vienna, Austria
Dr. Christa Noehammer and Dr. Winfried Neuhaus

ESR5

EVs as surrogated biomarkers of prostate cancer metabolism

CIC bioGUNE, Asociacion Centro de Investigacion Cooperative en Biociencias, Derio, Spain
Prof. dr. Juan M. Falcón-Perez

ESR6

Tracking endogenous prostate cancer-derived EVs in vivo

INSERM – Institute of Psychiatry and Neurosciences of Paris, France
Dr. Guillaume van Niel

ESR7

EV dissemination in the lymphatic system and pre-metastatic niche formation

ESR8

Coding and non-coding RNA in prostate cancer-derived EVs

GenomeScan B.V., Leiden, The Netherlands
Dr. Inès Beumer

ESR9

Network-based computational methods for EV datasets analysis

Anaxomics Biotech, S.L., Barcelona, Spain
Dr. Judith Farrés & Dr. José Manuel Mas

ESR10

EVs as drug delivery system

University Medical Center Utrecht, Utrecht, The Netherlands
Prof. dr. Raymond Schiffelers